Elie Lily to build a 5 billion dollar medicine manufacturer in Virginia

Elie Lily announced plans on Tuesday to build a 5 billion dollar medicine manufacturing facility in Virginia. This announcement comes amid pressure from President Donald Trump to bring more drug manufacturing to the United States and threats to slap heavy customs duties on drugs coming from abroad.

The new manufacturing factory, west of Richmond, Virginia, will be built in Jakhnd County, according to press release From the company. Eli Lily says he expects the project to be completed within five years and claims that he will attend “more than 650 new jobs with a large -scale for Virginia, including high skills, scientists, operations employees and laboratory technicians.”

ELI Lilly Journalist’s statement included a statement issued by Virginia Governor Glenn Yongen, who also indicated the number of building functions that will be brought to the state.

“Lily is one of the great creators in the world, and I would like to thank them for this important commitment to Virginia.” “This new facility will create in Goochland 650 great jobs, along with 1,800 building jobs, and provide some of the most advanced medicines in a Lilly portfolio, supported by unparalleled talent for the workforce in Virginia.”

Yongen’s description, a Republican, the benefits of the American supply chain, which is severely disrupted during the Covid-19s, which leads to calls to bring more drugs to the United States

“By expanding the ability of manufacturing here in the United States, we strengthen our economy, secure the supply chain of critical drugs in America, and placed in Virginia to lead in industries that will lead innovation for future generations,” said Yukeen.

Lilly announced for the first time in February that it will invest more than 27 billion dollars in new manufacturing facilities, bringing its total investments. 50 billion dollars Since 2020. The company said on Tuesday that three other American manufacturing sites will be announced soon. All four sites are expected to make medicines within five years, according to the company.

“This is not just another manufacturing site – it represents an important milestone for Lilly, as we start building our first Bioconjugate facility,” Edgardo Hernandez, Executive Vice President and Night Manufacturing Chairman, said in a press statement.

“With this advanced location, Lilly defines a new standard in innovation bioconjugate, as the technologies that will expand what is possible for patients,” Hernandez continued. “This investment reflects our bold vision, our commitment to transformational technologies and our dedication to be a good neighbor through sustainability efforts, support for local education and community partnerships.”

Trump initially threatened in July to impose a 200 % tariff on the prescribed drugs from abroad, although the number jumped in August from 150 % to 250 %, he said. CNBC. At that time, Trump said he would begin to impose this tariff within a year or a year and a half, although the president is known to move the final dates forward and backward.

Aside from an attempt to bring drug manufacture to the United States, President Trump also tried to pressure pharmaceutical companies to reduce prices, although he seemed to have had less luck in trying to do this simply by decree.